Product Information

BROMFENAC SODIUM 0.09% EYE DRP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $15.0851 per ML under NDC 62332050817. Its NADAC has been published 366 times since Nov 13, 2019.

FDA first approved this application on Jun 21, 2019. Its Orange Book therapeutic-equivalence code is AT2.

BROMFENAC SODIUM 0.09% EYE DRP

Bromfenac Ophthalmic Solution 0.09%
$15.0851per ML

Strength

1.035 mg/mL

NDC

62332050817

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA210560

FDA Approved

6/21/2019

TE Code

AT2

On Market Since

6/21/2019

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.09% EYE DRP has been published 366 times since Nov 13, 2019, and over the history we have for it it has declined 84.9%. The table below summarizes its recorded NADAC range and movement.

Current price$15.0851 per ML
All-time high$100.1941 (Nov 13, 2019)
All-time low$15.0851 (Oct 21, 2026)
52-week high$20.2795
52-week low$15.0851
Median price$59.1419
Average price$55.3254
Largest weekly change-52.1% (Apr 17, 2024)
Weeks tracked366
Tracking sinceNov 13, 2019

Price History

1W

0.0%

1M

-3.5%

3M

-3.7%

6M

-6.1%

1Y

-31.4%

3Y

-62.9%

5Y

-76.1%

All

-84.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bromfenac Ophthalmic Solution 0.09% market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.09% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.09% EYE DRP, manufactured by Alembic Pharmaceuticals Inc., is $15.0851 per ML (NDC 62332050817), effective Nov 11, 2026.

How has the price of BROMFENAC SODIUM 0.09% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has declined 84.9%. It has been tracked across 366 weekly CMS publications since Nov 13, 2019.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.09% EYE DRP?

Since Nov 13, 2019, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has ranged from a low of $15.0851 (Oct 21, 2026) to a high of $100.1941 (Nov 13, 2019), with a median of $59.1419 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.09% EYE DRP?

No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SODIUM 0.09% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BROMFENAC SODIUM 0.09% EYE DRP?

BROMFENAC SODIUM 0.09% EYE DRP (NDC 62332050817) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.